Want to see SCL full AI Analyst Report?
EarningsQ2 2026 Earnings Report
SCL Q2 2026 EPS Results
Actual EPS$1.18
Consensus EPS$0.61
Beat/MissBeat by +$0.57
One Year Ago EPS$0.52
SCL Q2 2026 Revenue Results
Actual Revenue$684.11M
Expected Revenue$635.85M
Beat/MissBeat by +$48.26M
YoY Revenue Growth+15.04%
Earnings Announcement Details
QuarterQ2 2026
Date07/29/2026
TimeBefore Open
Conference CallWednesday, July 29, 2026
SCL Upcoming Earnings
Stepan Company's next earnings date is estimated for October 28, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
SCL Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented strong operational and financial performance: double-digit revenue growth, a 45% increase in adjusted EBITDA, and substantial improvements in adjusted earnings per share. Project Catalyst savings are ramping and balance sheet deleveraging is progressing. However, the quarter also included meaningful restructuring charges and a negative free cash flow impacted by a large working capital build and ongoing raw material volatility. Management signaled some portion of Q2 strength may reflect customer pre-buying ($5–$10 million of EBITDA) and flagged H2 maintenance and restructuring cash impacts. On balance, the positive drivers (broad-based volume growth, margin recovery, and on-track cost savings) outweigh the transitional challenges and one-time charges.Company Guidance
Strong EBITDA and Earnings Expansion
Adjusted EBITDA of $74.4 million, up 45% year-over-year. Adjusted net income of $27.1 million (adjusted EPS $1.18), up 126% versus prior year. Reported net income was $22.9 million or $1.00 per diluted share, up 102% year-over-year.
Revenue Growth
Consolidated net sales of $684 million, up 15% versus prior year, driven by higher selling prices, higher volumes, favorable product/customer mix, and currency translation.
Broad-Based Volume Growth
Organic volume growth of 6% consolidated, with surfactants organic volume +7% and polymers sales volume +5%. Growth was broad-based across end markets including industrial cleaning, laundry, construction, oil field and Tier 2/Tier 3 customers.
Surfactants Segment Outperformance
Surfactants net sales $484 million, up 18% year-over-year; selling prices up 12%; reported volume up 3% and organic volume up 7%. Surfactant adjusted EBITDA $55 million, up 59% versus prior year.
Polymers Segment Momentum
Polymers net sales $178 million, up 9% year-over-year; selling prices up 3%; volume up 5%. Polymer adjusted EBITDA $31 million, up 22% year-over-year, driven by North American rigid polyols and spray foam growth.
Project Catalyst Progress
Project Catalyst on track: program expected to deliver ~$100 million pre-tax savings over two years with ~60% of savings in 2026. Company indicated delivering more than the committed ~$60 million pre-tax savings for the year, with current run-rate savings of $18–$20 million per quarter and an expected ~22 million quarterly run-rate by year-end.
Balance Sheet and Deleveraging Progress
Net debt of $534 million and net leverage ratio improved to 2.5x (from 2.7x in Q1 and 2.9x year-ago), demonstrating progress on deleveraging efforts.
Operational and Safety Achievements
Strong safety performance (best on record over the last 12 months). Pasadena ramp-up nearing target (reported ~75–80% utilization), Millsdale production and operating metrics improving, and continued execution of capex plan.
SCL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed